Serotonin Effectors Expressed during Palatogenesis: An Immunohistochemical Study
Serotonin Effectors Expressed during Palatogenesis: An Immunohistochemical Study
复制标题
DOI:
--
复制
发表时间:
2018
期刊:
影响因子:
--
通讯作者:
Hirata;Imura;Sugahara;Natsume;H. Nakamura;Y. Kondo
中科院分区:
文献类型:
--
作者:
Hirata;Imura;Sugahara;Natsume;H. Nakamura;Y. Kondo
Serotonin transporter (SERT) is one of the most critical regulators of the orchestration of serotonin (5-hydroxytryptamine; 5-HT) signaling through removal of extracellular 5-HT. Early studies have shown that 5-HT regulates craniofacial morphogenesis through interaction with 5-HT receptors or SERT. To determine the characteristics of 5-HT and SERT in palate development, we examined their localization immunohistochemically during secondary palate formation in mice. We also examined the immunolocalization of monoamine oxidase (MAO), a major metabolic enzyme of 5-HT, and tryptophan hydroxylase (TPH), a synthetic enzyme of 5-HT, to clarify their relationship with 5-HT in palatogenesis. Immunohistochemically, in the palatal shelves in the vertical position, diffuse localization of 5-HT was observed in the palatal mesenchyme, whereas SERT, MAO, and TPH immune reactivities were weak. When the palatal shelves were oriented horizontally, similar immune reactivities of 5-HT, SERT, MAO, and TPH were observed in the cells of the outer epithelial layer of the palatal shelf. In addition, 5-HT, SERT, MAO, and TPH immunoreactivities were detected in the medial epithelial seam (MES) of fused palatal shelves, and with the progression of palate formation, these immunoreactivities were subsequently observed in the basal and middle layers of the palatal epithelium. These findings suggest that serotonergic regulation via SERT is involved in palatogenesis, particularly in the development of the palatal epithelium. Our findings imply that altered 5-HT metabolism increases the risk of congenital craniofacial anomalies, such as clefting, in the children of women who are exposed to selective serotonin reuptake inhibitors (SSRIs) during pregnancy